The studies incorporated had urinary amylase or urinary trypsinogen-2 as the index test, and serum amylase, serum lipase, or imaging tests (CT, MRI, ultrasound) served as the reference tests to validate AP. The gene discussed is PRSS2; the disease is alkaline phosphatase measurement.